| 000 | 02930nam a2200445 i 4500 | ||
|---|---|---|---|
| 999 |
_c127410 _d127410 |
||
| 001 | 127410 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102114244.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 200901s2020 gw a s |||| 0|eng d | ||
| 020 | _a9783030580049 | ||
| 024 | 7 |
_a10.1007/978-3-030-58004-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQR189 _b2020 EB |
|
| 245 | 0 | 0 |
_aVaccination Strategies Against Highly Variable Pathogens _cedited by Lars Hangartner, Dennis R. Burton |
| 250 | _aFirst edition 2020 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2020 |
|
| 300 |
_a1 recurso en línea (VII, 180 páginas) _b16 ilustraciones, 15 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aArchivo de texto _bPDF |
||
| 490 | 0 |
_aCurrent Topics in Microbiology and Immunology _x0070-217X _v428 |
|
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-43708) | |
| 505 | 0 | _aSuccessful Vaccines -- Immunogenicity and Immunodominance in Antibody Responses -- Immunogen Design -- Adjuvants -- Tools to screen vaccines -- Targeting glycans on human pathogens for vaccine design -- BnAbs and highly antigenically variable pathogens. | |
| 520 | 3 | _aVaccines against antigenically stable pathogens, or pathogens that only exist in a limited number of serotypes, have been very successful in the past and have drastically decreased the incidence and lethality of many diseases. However, when it comes to highly variable pathogens or viruses that exist in multiple serotypes, the traditional methods for vaccine development have reached their limits. This volume highlights the development of vaccines against such challenging pathogens. Novel approaches for immunogen design, including structure-guided vaccine development and vaccines targeting glycans, as well as adjuvants and animal models used for testing possible vaccine candidates are outlined and discussed in detail. Given its scope, the book will appeal to scientists in the fields of infectious diseases, microbiology and medicine | |
| 988 | _aSpringer_BiomedLife_13102020 | ||
| 650 | 7 |
_2embne _aVacunas _9140409 |
|
| 700 | 1 |
_aHangartner, Lars _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aBurton, Dennis R _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030580032 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030580056 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030580063 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-58004-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b11/2020 _dz _ek _zSI |
||